FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Gerald McMahon

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Mastocytosis

Genes & Molecular Sequences

Proto-Oncogenes

Concepts & Ideas

Physiology

Occupations

Drug Design

Register to see full profile

Co-author Network

Co-Publications
Name
3
Jack Longley
3
Yongsheng Ma
1
Dean Metcalfe
1
Xiuhua Wang
1
Shan Zeng
1
Cem Akin

Register to see all co-authors

Publications

TOP 3
Yongsheng Ma; Shan Zeng; Dean D Metcalfe; Cem Akin; Sasa Dimitrijevic; Joseph H Butterfield; Gerald McMahon; B Jack Longley
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.
B Jack Longley; Yongsheng Ma; E Carter; Gerald McMahon
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors.
Yongsheng Ma; E Carter; Xiuhua Wang; C Shu; Gerald McMahon; B Jack Longley
Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Gerald McMahon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2002: Yongsheng Ma; Shan Zeng; Dean D Metcalfe; Cem Akin; Sasa Dimitrijevic; Joseph H Butterfield; Gerald McMahon; B Jack Longley
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.
Blood 2002;99(5):1741-4.
2000: B Jack Longley; Yongsheng Ma; E Carter; Gerald McMahon
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors.
Hematology/oncology clinics of North America 2000;14(3):689-95.
2000: Yongsheng Ma; E Carter; Xiuhua Wang; C Shu; Gerald McMahon; B Jack Longley
Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells.
The Journal of investigative dermatology 2000;114(2):392-4.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.